Aruni Ghose: Pleasure Catching Up with Ankit Jain and Exploring OncoFlow’s Future at Apollo Hospitals
Aruni Ghose, Chief Medical Officer at OncoFlow and Internal Medicine Resident at Barts Health NHS Trust, shared a post on LinkedIn:
“The legendary Ankit Jain has been an incredible Oncology mentor – we were part of 2 landmark Cancer Real World Studies
2023 First UK experience of apalutamide in metastatic and non-metastatic prostate cancer outside of clinical trials – American Society of Clinical Oncology (ASCO)
2024 External validation of the novel prognostic Meet-URO score in Metastatic Renal Cell Carcinoma on First Line Immune-combination therapy – International Urology Cancer Summit
As one of the Advisors to the OncoFlow team (Maryam Hasanova and myself), it was such a pleasure to catch up with him and get introduced to Dr. Gaurav Katyal (COO) and Devashish Tripathi at their Oncology Centre of Excellence Indraprastha Apollo Hospitals , New Delhi – Exciting days ahead for the OncoFlow clinical adoption and implementation.”
Aruni Ghose is an internal medicine resident at Barts Health NHS Trust. He is the Chief Medical Officer of OncoFlow. Additionally, he serves as a Focused Topic Network Member at the European Cancer Organisation and sits on the Editorial Board at BMC. His research focuses on Genitourinary Cancer, Immuno Oncology, Global Oncology, Cardio Oncology, and Lung Cancer. Aruni Ghose started a new position as a Research Fellow at The Lancet Oncology Commission on Cancer in the Commonwealth.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023